Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Translating chemometric analysis into physiological insights from in vivo confocal Raman spectroscopy of the human stratum corneum.

Perticaroli S, Yeomans DJ, Wireko FC, Webber JT, Werchowski KM, Cambron RT, Ray PJ.

Biochim Biophys Acta Biomembr. 2019 Feb 1;1861(2):403-409. doi: 10.1016/j.bbamem.2018.11.007. Epub 2018 Nov 19.

PMID:
30465747
2.

Integration of Tumor Genomic Data with Cell Lines Using Multi-dimensional Network Modules Improves Cancer Pharmacogenomics.

Webber JT, Kaushik S, Bandyopadhyay S.

Cell Syst. 2018 Nov 28;7(5):526-536.e6. doi: 10.1016/j.cels.2018.10.001. Epub 2018 Nov 7.

3.

Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy in breast cancer.

Donnella HJ, Webber JT, Levin RS, Camarda R, Momcilovic O, Bayani N, Shah KN, Korkola JE, Shokat KM, Goga A, Gordan JD, Bandyopadhyay S.

Nat Chem Biol. 2018 Aug;14(8):768-777. doi: 10.1038/s41589-018-0081-9. Epub 2018 Jun 25.

4.

An Optimized Chromatographic Strategy for Multiplexing In Parallel Reaction Monitoring Mass Spectrometry: Insights from Quantitation of Activated Kinases.

Urisman A, Levin RS, Gordan JD, Webber JT, Hernandez H, Ishihama Y, Shokat KM, Burlingame AL.

Mol Cell Proteomics. 2017 Feb;16(2):265-277. doi: 10.1074/mcp.M116.058172. Epub 2016 Dec 11.

6.

Synthetic Lethal Targeting of ARID1A-Mutant Ovarian Clear Cell Tumors with Dasatinib.

Miller RE, Brough R, Bajrami I, Williamson CT, McDade S, Campbell J, Kigozi A, Rafiq R, Pemberton H, Natrajan R, Joel J, Astley H, Mahoney C, Moore JD, Torrance C, Gordan JD, Webber JT, Levin RS, Shokat KM, Bandyopadhyay S, Lord CJ, Ashworth A.

Mol Cancer Ther. 2016 Jul;15(7):1472-84. doi: 10.1158/1535-7163.MCT-15-0554. Epub 2016 Jun 30.

7.

Isocitrate Dehydrogenase Mutations Confer Dasatinib Hypersensitivity and SRC Dependence in Intrahepatic Cholangiocarcinoma.

Saha SK, Gordan JD, Kleinstiver BP, Vu P, Najem MS, Yeo JC, Shi L, Kato Y, Levin RS, Webber JT, Damon LJ, Egan RK, Greninger P, McDermott U, Garnett MJ, Jenkins RL, Rieger-Christ KM, Sullivan TB, Hezel AF, Liss AS, Mizukami Y, Goyal L, Ferrone CR, Zhu AX, Joung JK, Shokat KM, Benes CH, Bardeesy N.

Cancer Discov. 2016 Jul;6(7):727-39. doi: 10.1158/2159-8290.CD-15-1442. Epub 2016 May 26.

8.

An ontogenetic framework linking locomotion and trabecular bone architecture with applications for reconstructing hominin life history.

Raichlen DA, Gordon AD, Foster AD, Webber JT, Sukhdeo SM, Scott RS, Gosman JH, Ryan TM.

J Hum Evol. 2015 Apr;81:1-12. doi: 10.1016/j.jhevol.2015.01.003. Epub 2015 Mar 3.

PMID:
25743432
9.

Oncogene mimicry as a mechanism of primary resistance to BRAF inhibitors.

Sos ML, Levin RS, Gordan JD, Oses-Prieto JA, Webber JT, Salt M, Hann B, Burlingame AL, McCormick F, Bandyopadhyay S, Shokat KM.

Cell Rep. 2014 Aug 21;8(4):1037-48. doi: 10.1016/j.celrep.2014.07.010. Epub 2014 Aug 7.

10.

Library dependent LC-MS/MS acquisition via mzAPI/Live.

Webber JT, Askenazi M, Ficarro SB, Iglehart MA, Marto JA.

Proteomics. 2013 May;13(9):1412-6. doi: 10.1002/pmic.201200583.

11.

Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins.

Rozenblatt-Rosen O, Deo RC, Padi M, Adelmant G, Calderwood MA, Rolland T, Grace M, Dricot A, Askenazi M, Tavares M, Pevzner SJ, Abderazzaq F, Byrdsong D, Carvunis AR, Chen AA, Cheng J, Correll M, Duarte M, Fan C, Feltkamp MC, Ficarro SB, Franchi R, Garg BK, Gulbahce N, Hao T, Holthaus AM, James R, Korkhin A, Litovchick L, Mar JC, Pak TR, Rabello S, Rubio R, Shen Y, Singh S, Spangle JM, Tasan M, Wanamaker S, Webber JT, Roecklein-Canfield J, Johannsen E, Barabási AL, Beroukhim R, Kieff E, Cusick ME, Hill DE, Münger K, Marto JA, Quackenbush J, Roth FP, DeCaprio JA, Vidal M.

Nature. 2012 Jul 26;487(7408):491-5. doi: 10.1038/nature11288.

12.

Nanoflow low pressure high peak capacity single dimension LC-MS/MS platform for high-throughput, in-depth analysis of mammalian proteomes.

Zhou F, Lu Y, Ficarro SB, Webber JT, Marto JA.

Anal Chem. 2012 Jun 5;84(11):5133-9. doi: 10.1021/ac2031404. Epub 2012 May 10.

13.

C/EBPα and DEK coordinately regulate myeloid differentiation.

Koleva RI, Ficarro SB, Radomska HS, Carrasco-Alfonso MJ, Alberta JA, Webber JT, Luckey CJ, Marcucci G, Tenen DG, Marto JA.

Blood. 2012 May 24;119(21):4878-88. doi: 10.1182/blood-2011-10-383083. Epub 2012 Apr 3.

14.
15.

Online nanoflow multidimensional fractionation for high efficiency phosphopeptide analysis.

Ficarro SB, Zhang Y, Carrasco-Alfonso MJ, Garg B, Adelmant G, Webber JT, Luckey CJ, Marto JA.

Mol Cell Proteomics. 2011 Nov;10(11):O111.011064. doi: 10.1074/mcp.O111.011064. Epub 2011 Jul 25.

16.

mzServer: web-based programmatic access for mass spectrometry data analysis.

Askenazi M, Webber JT, Marto JA.

Mol Cell Proteomics. 2011 May;10(5):M110.003988. doi: 10.1074/mcp.M110.003988. Epub 2011 Jan 25.

17.

mzResults: an interactive viewer for interrogation and distribution of proteomics results.

Webber JT, Askenazi M, Marto JA.

Mol Cell Proteomics. 2011 May;10(5):M110.003970. doi: 10.1074/mcp.M110.003970. Epub 2011 Jan 25.

18.

multiplierz: an extensible API based desktop environment for proteomics data analysis.

Parikh JR, Askenazi M, Ficarro SB, Cashorali T, Webber JT, Blank NC, Zhang Y, Marto JA.

BMC Bioinformatics. 2009 Oct 29;10:364. doi: 10.1186/1471-2105-10-364.

19.

Public Health Measures in an Influenza Pandemic - the importance of surveillance.

Nicoll A; Influenza Project Team, Ciancio B, de la Hoz KF, Kreidl P, Needham H, Varela C, Vasconcelos P, Webber JT, Wurz A.

Euro Surveill. 2007 Nov 1;12(11):E071101.4. No abstract available.

20.

Treatment of atherosclerotic ostial renal artery stenosis with the intravascular stent.

Tuttle KR, Chouinard RF, Webber JT, Dahlstrom LR, Short RA, Henneberry KJ, Dunham LA, Raabe RD.

Am J Kidney Dis. 1998 Oct;32(4):611-22.

PMID:
9774123
21.

The cerebral ventricles: a computer-based interactive tutorial.

Webber JT, Osborn AG, Stensaas SS, Burrows PE, Wald KM, Sundsten JW, Pingree JC.

Radiographics. 1995 May;15(3):697-702.

PMID:
7624573

Supplemental Content

Loading ...
Support Center